TK1 and neoplasm: Because a reduced cell death after chemotherapy is unlikely, possible reasons for a diminished inflow of TK1 into the blood could be due to a transient obstruction of the flow of cells through cell cycles, combined with sustained cell death, or due to increased clearance of disrupted tumor cells by mechanisms other than those resulting in the release of TK1 into the circulation.